Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported $42.13M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
AbbVie USD 9.39B 4.16B Mar/2026
Actinium Pharmaceuticals USD 42.13M 5.87M Mar/2026
Amgen USD 12.04B 2.91B Mar/2026
Bioline Rx USD 7.91M 725K Sep/2025
Capricor Therapeutics USD 287.85M 268.34M Dec/2025
Pfizer USD 1.7B 561M Mar/2026